Humaid Al-Shamsi, The Chairman of Nexomic, CEO of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on LinkedIn:
“We at ‘Nexomic’ are pleased to announce Prof. Massimo Cristofanilli as a member of Nexomic Advisory Board.
His internationally recognised expertise and leadership in precision oncology will strengthen Nexomic’s mission to translate advanced cancer biology into meaningful clinical impact and to continue our mission in decoding cancer and drug discovery using our award winning Deepomic foundation platform.”
Other articles featuring Massimo Cristofanilli on OncoDaily.